Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does FOSAPREPITANT Cause C-reactive protein abnormal? 63 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 63 reports of C-reactive protein abnormal have been filed in association with FOSAPREPITANT. This represents 12.9% of all adverse event reports for FOSAPREPITANT.

63
Reports of C-reactive protein abnormal with FOSAPREPITANT
12.9%
of all FOSAPREPITANT reports
63
Deaths
63
Hospitalizations

How Dangerous Is C-reactive protein abnormal From FOSAPREPITANT?

Of the 63 reports, 63 (100.0%) resulted in death, 63 (100.0%) required hospitalization, and 63 (100.0%) were considered life-threatening.

Is C-reactive protein abnormal Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for FOSAPREPITANT. However, 63 reports have been filed with the FAERS database.

What Other Side Effects Does FOSAPREPITANT Cause?

Dyspnoea (195) Infusion related reaction (167) Hypersensitivity (157) Duodenal ulcer perforation (155) Confusional state (149) Glossodynia (149) Folliculitis (146) Arthralgia (144) Blister (144) Discomfort (144)

What Other Drugs Cause C-reactive protein abnormal?

METHOTREXATE (3,734) ADALIMUMAB (3,629) ETANERCEPT (3,592) ABATACEPT (3,402) LEFLUNOMIDE (3,279) TOCILIZUMAB (3,259) HYDROXYCHLOROQUINE (3,245) SULFASALAZINE (2,823) INFLIXIMAB (2,676) RITUXIMAB (2,608)

Which FOSAPREPITANT Alternatives Have Lower C-reactive protein abnormal Risk?

FOSAPREPITANT vs FOSAPREPITANT DIMEGLUMINE FOSAPREPITANT vs FOSCARBIDOPA\FOSLEVODOPA FOSAPREPITANT vs FOSCARNET FOSAPREPITANT vs FOSFOMYCIN FOSAPREPITANT vs FOSFOMYCIN TROMETHAMINE

Related Pages

FOSAPREPITANT Full Profile All C-reactive protein abnormal Reports All Drugs Causing C-reactive protein abnormal FOSAPREPITANT Demographics